These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7193269

  • 1. Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin.
    Swann AC, Maas JW, Hattox SE, Landis H.
    Life Sci; 1980 Nov 17; 27(20):1857-62. PubMed ID: 7193269
    [No Abstract] [Full Text] [Related]

  • 2. Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTP.
    Kopin IJ, Bankiewicz KS, Harvey-White J.
    Neuropsychopharmacology; 1988 May 17; 1(2):119-25. PubMed ID: 3266957
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous determination of unconjugated homovanillic acid, vanilmandelic acid, and 3-methoxy-4-hydroxyphenylethylene glycol, in serum by mass fragmentography and deuterated internal standards.
    Muskiet FA, Nagel GT, Wolthers BG.
    Anal Biochem; 1980 Nov 15; 109(1):130-6. PubMed ID: 7469009
    [No Abstract] [Full Text] [Related]

  • 4. Diurnal changes in dopamine-beta-hydroxylase, homovanillic acid and 3-methoxy-4-hydroxyphenylglycol in serum of man.
    Markianos E, Backman H.
    J Neural Transm; 1976 Nov 15; 39(1-2):79-93. PubMed ID: 988114
    [Abstract] [Full Text] [Related]

  • 5. Differential effects on brain catecholamines by debrisoquin.
    Maas JW, Hattox SE, Landis DH.
    Biochem Pharmacol; 1979 Oct 15; 28(20):3153-6. PubMed ID: 117812
    [No Abstract] [Full Text] [Related]

  • 6. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB, Swigar ME, Jatlow PI, Goicoechea N.
    J Clin Psychiatry; 1984 Jun 15; 45(6):248-51. PubMed ID: 6725216
    [Abstract] [Full Text] [Related]

  • 7. Plasma catecholamine metabolites in subtypes of major depression.
    Mazure CM, Bowers MB, Hoffman F, Miller KB, Nelson JC.
    Biol Psychiatry; 1987 Dec 15; 22(12):1469-72. PubMed ID: 3676373
    [No Abstract] [Full Text] [Related]

  • 8. Plasma homovanillic acid as an index of brain dopamine metabolism: enhancement with debrisoquin.
    Sternberg DE, Heninger GR, Roth RH.
    Life Sci; 1983 May 23; 32(21):2447-52. PubMed ID: 6855448
    [Abstract] [Full Text] [Related]

  • 9. Acute psychosis and plasma catecholamine metabolites.
    Bowers MB, Swigar ME.
    Arch Gen Psychiatry; 1987 Feb 23; 44(2):190. PubMed ID: 3813817
    [No Abstract] [Full Text] [Related]

  • 10. Plasma catecholamine metabolites and treatment response at neuroleptic steady state.
    Bowers MB, Swigar ME, Jatlow PI, Hoffman FJ.
    Biol Psychiatry; 1989 Mar 15; 25(6):734-8. PubMed ID: 2923935
    [Abstract] [Full Text] [Related]

  • 11. Acute and subacute effects of ECT on plasma HVA, MHPG, and prolactin.
    Devanand DP, Bowers MB, Hoffman FJ, Sackeim HA.
    Biol Psychiatry; 1989 Aug 15; 26(4):408-12. PubMed ID: 2765601
    [No Abstract] [Full Text] [Related]

  • 12. Characteristics of patients with the highest plasma catecholamine metabolite levels.
    Bowers MB, Swigar ME, Hoffman FJ, Goicoechea N.
    Am J Psychiatry; 1988 Feb 15; 145(2):246-8. PubMed ID: 3422545
    [Abstract] [Full Text] [Related]

  • 13. Elevated plasma homovanillic acid in depressed females with melancholia and psychosis.
    Devanand DP, Bowers MB, Hoffman FJ, Nelson JC.
    Psychiatry Res; 1985 May 15; 15(1):1-4. PubMed ID: 3859880
    [Abstract] [Full Text] [Related]

  • 14. Effects of debrisoquin on CSF and plasma HVA concentrations in man.
    Maas JW, Contreras SA, Bowden CL, Weintraub SE.
    Life Sci; 1985 Jun 03; 36(22):2163-70. PubMed ID: 3999921
    [Abstract] [Full Text] [Related]

  • 15. Early neuroleptic response in psychotic men and women: correlation with plasma HVA and MHPG.
    Bowers MB, Swigar ME, Jatlow PI, Hoffman F, Giocoechea N.
    Compr Psychiatry; 1986 Jun 03; 27(3):181-5. PubMed ID: 2872015
    [No Abstract] [Full Text] [Related]

  • 16. Simultaneous determination of free homovanillic acid, (3-methoxy-4-hydroxyphenyl)ethylene glycol, and vanilmandelic acid in human plasma by high-performance liquid chromatography coupled with dual-electrode coulometric electrochemical detection.
    Gerhardt GA, Drebing CJ, Freedman R.
    Anal Chem; 1986 Nov 03; 58(13):2879-83. PubMed ID: 3813021
    [No Abstract] [Full Text] [Related]

  • 17. Early neuroleptic response: clinical profiles and plasma catecholamine metabolites.
    Bowers MB, Swigar ME, Jatlow PI, Hoffman FJ, Goicoechea N.
    J Clin Psychopharmacol; 1987 Apr 03; 7(2):83-6. PubMed ID: 2884237
    [Abstract] [Full Text] [Related]

  • 18. Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.
    Riddle MA, Leckman JF, Cohen DJ, Anderson M, Ort SI, Caruso KA, Shaywitz BA.
    J Neural Transm; 1986 Apr 03; 67(1-2):31-43. PubMed ID: 3465864
    [Abstract] [Full Text] [Related]

  • 19. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M, Losonczy MF, Mohs RC, Lesser JC, Powchik P, Freed LB, Davis BM, Mykytyn VV, Davis KL.
    Neuropsychopharmacology; 1987 Dec 03; 1(1):17-23. PubMed ID: 3509064
    [Abstract] [Full Text] [Related]

  • 20. Brain contribution to the haloperidol-induced increase in plasma homovanillic acid.
    Kendler KS, Heninger GR, Roth RH.
    Eur J Pharmacol; 1981 May 08; 71(2-3):321-6. PubMed ID: 7250191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.